Plasma Derived Therapy Market Revenue to Attain USD 39.90 Bn by 2033

21 Oct 2024

Share :

Table of Content

1. Plasma Derived Therapy Market Revenue and Trends 2. Market Overview 3. Highlights of the Plasma Derived Therapy Market Report 4. Plasma Derived Therapy Market Trends 5. Regional Insights 6. Plasma Derived Therapy Market Coverage 7. Market News

Plasma Derived Therapy Market Revenue and Trends

The global plasma derived therapy market revenue was valued at USD 21.88 billion in 2024 and is expected to attain around USD 39.90 billion by 2033, growing at a CAGR of 6.90% during forecast period. The demand for plasma derived therapy is increasing with the increasing cases of rare diseases. 

Market Overview

Plasma-derived therapy refers to the treatment that uses human plasma for the treatment of complex diseases. With time, there has been a drastic increase in rare diseases, such as immunodeficiency diseases and idiopathic thrombocytopenic purpura. The increasing number of people suffering from chronic diseases that do not find a suitable treatment with the help of modern medicine make use of plasma-derived therapy, which has shown a considerable effect in such patients. A huge number of patients who are suffering from genetic disorders also find a suitable treatment option with the help of plasma-derived therapies. 

Increasing investment by governments and prominent companies to develop better treatment with cutting-edge technologies propel the market. In addition, there is a widespread adoption of immunoglobulin which is expected to boost the plasma-derived therapy market in the upcoming years.

Highlights of the Plasma Derived Therapy Market Report

• Based on product, the immunoglobulin segment is anticipated expand at the fastest CAGR in the coming years due to its increasing demand in chronic disease treatments. The numerous benefits offered by the usage of immunoglobulin have emerged as a major growth factor for the segment. 
• Based on application, the hemophilia segment is projected to grow rapidly in the market during the forecast period due to the increasing instances of hemophilia. However, plasma derived therapy is suitable for the treatment of this disorder due to its effectiveness. Increasing awareness among the people regarding the availability of treatment further fuels the segment. 

Plasma Derived Therapy Market Trends

Increasing investment:

With time, there has been a rapid increase in investment in the plasma-derived therapy. Governments in many countries have begun investing heavily in the development of technologies with cutting-edge features that will help patients achieve desired outcomes. The development of smart technologies has also led to improvements in the capabilities of medical procedures to offer better treatments to their patients.

Increase in collaborations and partnerships:

In recent times, there has been an increase in collaborations and partnerships among prominent companies, several institutions, etc. All these have led to the development of new technologies in the healthcare sector especially in the plasma-derived therapy market, making it more commercial than before.

Wider adoption of immunoglobulin:

The plasma-derived therapy market has been revolutionized by the widespread adoption of immunoglobulin which offers several benefits, making it the top choice for the treatment of immune deficiencies. 

Regional Insights

North America dominated the plasma derived therapy market with the largest revenue share, owing to the rising number of people suffering from rare and uncommon diseases. Moreover, the availability of advanced healthcare infrastructure and reimbursement policies for treatments contributed to regional market growth. The adoption of modern treatment options among the people has also helped the market to record considerable growth. The government has also launched several schemes to support the healthcare system and provide the best facilities to the people residing in the region. 

The market in Europe is expected to grow rapidly in the coming years due to advancements made in the healthcare sector by the government. On the other hand, Asia Pacific is expected to witness steady growth, owing to the increasing number of healthcare facilities and rising government focus to advance healthcare infrastructure.

Plasma Derived Therapy Market Coverage

Market News

• In August 2024, Nanoform Finland, a Finland-based medical technology company, joined hands with a Japanese pharmaceutical company, Takeda, to develop plasma-derived therapy. 
• In December 2023, Hairline International Hair and Skin Clinic, a leading hair clinic, unveiled an advanced hair generation therapy named Sonicated PRP to bring a change in hair follicle activation and regeneration.
• In April 2022, Akron BioProducts, a leading supplier of cGMP-compliant materials and technologies for cell and gene therapy manufacturing, announced the introduction of its Closed System Solutions line to facilitate the closing critical unit operations in cell and gene therapy manufacturing workflows.  

Market Segmentation

By Product

• Immunoglobulin
• Coagulation factors
• Albumin
• Others

By Application

• Hemophilia
• Primary immunodeficiency disease
• Idiopathic thrombocytopenic purpura
• Others

Get this report to explore global market size, share, CAGR and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/checkout/2058

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344